Aurora Cannabis Inc. (TSE:ACB - Get Free Report) fell 20.2% on Wednesday . The stock traded as low as C$6.31 and last traded at C$6.40. 1,868,867 shares changed hands during mid-day trading, an increase of 257% from the average session volume of 523,132 shares. The stock had previously closed at C$8.02.
Aurora Cannabis Stock Performance
The firm has a market cap of C$350.13 million, a P/E ratio of -7.90 and a beta of 2.71. The company has a current ratio of 3.42, a quick ratio of 2.48 and a debt-to-equity ratio of 18.72. The company's 50-day moving average is C$6.97 and its two-hundred day moving average is C$6.70.
About Aurora Cannabis
(
Get Free Report)
Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Aurora, CanniMed, Daily Special, MedReleaf, and San Rafael '71. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements or cultivation facilities in more than 20 countries.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Aurora Cannabis, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aurora Cannabis wasn't on the list.
While Aurora Cannabis currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
